TARA

Protara Therapeutics, Inc. TARA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $2.9M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$176.01M total
Jupiter Topco LLC
$17.92M--
BlackRock, Inc.
$13.99M+7.9%
MILLENNIUM MANAGEMENT LLC
$11.85M+9.5%
Velan Capital Investment Management LP
$10.87M+0.4%
VANGUARD CAPITAL MANAGEMENT LLC
$8.79M+8.5%
Blackstone Inc.
$8.65M0.0%
ORBIMED ADVISORS LLC
$8.48MNew
Sio Capital Management, LLC
$7.34M-2.4%
ACORN CAPITAL ADVISORS, LLC
$6.69M0.0%
Integral Health Asset Management, LLC
$5.73M-14.3%
5AM Venture Management, LLC
$5.23M0.0%
GEODE CAPITAL MANAGEMENT, LLC
$5.07M+12.7%
CITADEL ADVISORS LLC
$4.71M+15.3%
STATE STREET CORP
$4.08M+6.3%
Qube Research & Technologies Ltd
$3.99M+490.7%
BALYASNY ASSET MANAGEMENT L.P.
$3.92MNew
BAKER BROS. ADVISORS LP
$3.71M0.0%
ADAR1 Capital Management, LLC
$3.59M0.0%
BANK OF AMERICA CORP /DE/
$3.37M-4.7%
MARSHALL WACE, LLP
$2.68M+1281.8%
DIMENSIONAL FUND ADVISORS LP
$2.61M+28.6%
NORTHERN TRUST CORP
$2.11M+47.3%
Point72 Asset Management, L.P.
$2.10M-52.4%
GOLDMAN SACHS GROUP INC
$2.09M+37.2%
Catalio Capital Management, LP
$1.99M-10.3%
See all 120 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TARA

Earnings Per Share

13fpro.ai/company/TARA

Loading ratio trend…

TARA key financials by period

Reported revenue, net income and operating margin by fiscal year, from Protara Therapeutics, Inc.'s annual filings on SEC EDGAR.

Protara Therapeutics, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2014$2.9M$-3.3M—
Source: TARA filings on SEC EDGAR →

TARA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Protara Therapeutics, Inc. (TARA): stock profile, AI score and financials

Protara Therapeutics, Inc. (TARA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TARA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $2.9m in revenue and is scored on the micro-cap board instead. Top institutional holders of TARA by reported 13-F value include Jupiter Topco, BlackRock, MILLENNIUM MANAGEMENT, based on the most recent SEC filings. TARA trades on the Nasdaq exchange and files with the SEC under CIK 1359931. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TARA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Protara Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1359931 →